Related Experiment Video

Updated: Jun 27, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases

Hazel H Szeto1

  • 1Department of Pharmacology, Joan and Sanford I Weill Medical College of Cornell University, New York, NY 10021, USA. hhszeto@med.cornell.edu

Annals of the New York Academy of Sciences
|December 17, 2008
PubMed

Insights

Novel mitochondria-targeted peptides show promise for neurodegenerative diseases by protecting mitochondria and reducing oxidative stress. These peptides effectively cross the blood-brain barrier, offering new therapeutic potential for conditions like Parkinson's disease.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Pharmacology

Background:

  • Mitochondrial dysfunction and oxidative stress are key factors in neurodegenerative disease development.
  • A self-amplifying cycle exists between reactive oxygen species (ROS) generation and mitochondrial damage.
  • Current neuroprotective drug development faces challenges like blood-brain barrier penetration and mitochondrial delivery.

Purpose of the Study:

  • To develop novel mitochondria-targeted peptides for neuroprotection.
  • To evaluate the efficacy of these peptides in mitigating mitochondrial impairment and oxidative stress.

Main Methods:

  • Design and synthesis of mitochondria-targeted peptides.
  • Assessment of peptide effects on mitochondrial function, ROS generation, and permeability transition.
  • Evaluation of peptide efficacy in animal models of Parkinson's disease and amyotrophic lateral sclerosis.

Main Results:

  • The novel peptides effectively promote mitochondrial function.
  • Peptides significantly reduce mitochondrial ROS generation and inhibit the mitochondrial permeability transition.
  • Demonstrated neuroprotective effects in animal models, preventing apoptosis and necrosis.

Conclusions:

  • Mitochondria-targeted peptides offer a promising therapeutic strategy for neurodegenerative diseases.
  • These peptides overcome key delivery challenges, including blood-brain barrier penetration.
  • Further development of these peptides could lead to effective treatments for Parkinson's disease and ALS.

More Related Videos

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Related Concept Videos

Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...